Agency for Science, Technology and Research

Singapore Health Services Pte Ltd

Tessa Therapeutics Pte. Ltd

Euchloe Bio Pte. Ltd.

John Edward Connolly

Siok Ping Yeo

Peter Brauer

Cheng-I Wang

Hwee Ching Tan

Richard Hopkins

Jianrong Lionel Low

Junyun Lai

Kar Wai Tan

Cheng-l Wang

Han Chong Toh

Antigen binding molecules capable of binding to CD122 and/or common &#x3b3; chain (CD132) are disclosed herein. Also disclosed are compositions comprising such antigen binding molecules, and uses and methods using the same.

IL2Rbeta/common gamma chain antibodies

Anti-CD122 and/or &#x3b3;c antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

IL2R common gamma chain antibodies

Method for expansion of a population of cells with IL2R beta/common gamma chain antibodies

A method for predicting whether a patient will be a long-term survivor on treatment of a disease by adoptive cell transfer (ACT), is disclosed comprising: (i) analyzing a blood-derived sample obtained from the patient for one or more prognostic markers of long-term survival on treatment of a disease by ACT, and; (ii) based on the analysis of step (i), predicting whether the patient will be a long-term survivor on treatment of the disease by ACT. Also disclosed are methods for treating a patient by ACT, methods for selecting a patient for treatment by ACT, and methods for selecting a patient for treatment of a disease by ACT.

Method for treating epstein-barr virus&#x2014;positive cancer with immunotherapy

IL-2R beta/common gamma chain antibodies

Method of treating cancer using IL2R beta/common gamma chain antibodies

Growing community of inventors

Singapore, Singapore

John Edward Connolly